New drugs for reducing cardiovascular risk in women
DONALD G. VIDT, MD
HOLLY L. THACKER, MDADDRESS: Holly L. Thacker, MD, FACP, A91, The Cleveland, Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195.
HUSSEIN SAADI, MD
Atherosclerosis is largely preventable in women. Clinicians need to appreciate the gender-associated risks of cardiovascular disease and emphasize to their women patients that life-style changes can reduce cardiovascular risk. However, newer oral agents for diabetes and the statins for hyperlipidemia are important pharmacological adjuncts.